Help Patients Safely Continue the New Parkinson's Med Safinamide in the Hospital

July 2017

Safinamide (Xadago, ZAH-dah-goh) will be a new add-on for Parkinson's disease.

Think of safinamide as a me-too...similar to selegiline (Eldepryl, etc) or rasagiline (Azilect, etc).

These selective MAO-B inhibitors prevent dopamine breakdown to reduce "off-time"...when carbidopa/levodopa wears off and symptoms worsen.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote